ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Microbiomes Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-27U5631
Home | Market Reports | Health| Nursing
Global Microbiomes Market Insights and Forecast to 2028
BUY CHAPTERS

Global Microbiomes Market Research Report 2025

Code: QYRE-Auto-27U5631
Report
September 2025
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
4D Pharma
Enterome BioScience
Evelo Biosciences
Ferring
Osel
Second Genome
Seres Therapeutics
Synlogic
Synthetic Biologics and Vedanta Biosciences
Vedanta
Rebiotix
ActoGeniX
Enterologics
Metabogen
Metabiomics
Ritter Pharmaceuticals
AvidBiotics
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics LLC
SciBac Inc

Microbiomes Market

The global market for Microbiomes was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Microbiomes is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Microbiomes is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Microbiomes in Testing is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Microbiomes include 4D Pharma, Enterome BioScience, Evelo Biosciences, Ferring, Osel, Second Genome, Seres Therapeutics, Synlogic, Synthetic Biologics and Vedanta Biosciences, Vedanta, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Microbiomes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbiomes.
The Microbiomes market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Microbiomes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microbiomes companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Microbiomes Market Report

Report Metric Details
Report Name Microbiomes Market
Segment by Type
  • Gastrointestinal Microbiome
  • Genitourinary Microbiome
  • Skin Microbiome
  • Respiratory Microbiome
  • Other
Segment by Application
  • Testing
  • Treatment
  • Diagnosis
  • Technology Platform
  • Probiotics
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company 4D Pharma, Enterome BioScience, Evelo Biosciences, Ferring, Osel, Second Genome, Seres Therapeutics, Synlogic, Synthetic Biologics and Vedanta Biosciences, Vedanta, Rebiotix, ActoGeniX, Enterologics, Metabogen, Metabiomics, Ritter Pharmaceuticals, AvidBiotics, Symberix, Miomics, Symbiotix Biotherapies, MicroBiome Therapeutics LLC, SciBac Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Microbiomes company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Microbiomes Market report?

Ans: The main players in the Microbiomes Market are 4D Pharma, Enterome BioScience, Evelo Biosciences, Ferring, Osel, Second Genome, Seres Therapeutics, Synlogic, Synthetic Biologics and Vedanta Biosciences, Vedanta, Rebiotix, ActoGeniX, Enterologics, Metabogen, Metabiomics, Ritter Pharmaceuticals, AvidBiotics, Symberix, Miomics, Symbiotix Biotherapies, MicroBiome Therapeutics LLC, SciBac Inc

What are the Application segmentation covered in the Microbiomes Market report?

Ans: The Applications covered in the Microbiomes Market report are Testing, Treatment, Diagnosis, Technology Platform, Probiotics, Other

What are the Type segmentation covered in the Microbiomes Market report?

Ans: The Types covered in the Microbiomes Market report are Gastrointestinal Microbiome, Genitourinary Microbiome, Skin Microbiome, Respiratory Microbiome, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microbiomes Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Gastrointestinal Microbiome
1.2.3 Genitourinary Microbiome
1.2.4 Skin Microbiome
1.2.5 Respiratory Microbiome
1.2.6 Other
1.3 Market by Application
1.3.1 Global Microbiomes Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Testing
1.3.3 Treatment
1.3.4 Diagnosis
1.3.5 Technology Platform
1.3.6 Probiotics
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Microbiomes Market Perspective (2020-2031)
2.2 Global Microbiomes Growth Trends by Region
2.2.1 Global Microbiomes Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Microbiomes Historic Market Size by Region (2020-2025)
2.2.3 Microbiomes Forecasted Market Size by Region (2026-2031)
2.3 Microbiomes Market Dynamics
2.3.1 Microbiomes Industry Trends
2.3.2 Microbiomes Market Drivers
2.3.3 Microbiomes Market Challenges
2.3.4 Microbiomes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microbiomes Players by Revenue
3.1.1 Global Top Microbiomes Players by Revenue (2020-2025)
3.1.2 Global Microbiomes Revenue Market Share by Players (2020-2025)
3.2 Global Microbiomes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Microbiomes Revenue
3.4 Global Microbiomes Market Concentration Ratio
3.4.1 Global Microbiomes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microbiomes Revenue in 2024
3.5 Global Key Players of Microbiomes Head office and Area Served
3.6 Global Key Players of Microbiomes, Product and Application
3.7 Global Key Players of Microbiomes, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Microbiomes Breakdown Data by Type
4.1 Global Microbiomes Historic Market Size by Type (2020-2025)
4.2 Global Microbiomes Forecasted Market Size by Type (2026-2031)
5 Microbiomes Breakdown Data by Application
5.1 Global Microbiomes Historic Market Size by Application (2020-2025)
5.2 Global Microbiomes Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Microbiomes Market Size (2020-2031)
6.2 North America Microbiomes Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Microbiomes Market Size by Country (2020-2025)
6.4 North America Microbiomes Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Microbiomes Market Size (2020-2031)
7.2 Europe Microbiomes Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Microbiomes Market Size by Country (2020-2025)
7.4 Europe Microbiomes Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Microbiomes Market Size (2020-2031)
8.2 Asia-Pacific Microbiomes Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Microbiomes Market Size by Region (2020-2025)
8.4 Asia-Pacific Microbiomes Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Microbiomes Market Size (2020-2031)
9.2 Latin America Microbiomes Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Microbiomes Market Size by Country (2020-2025)
9.4 Latin America Microbiomes Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Microbiomes Market Size (2020-2031)
10.2 Middle East & Africa Microbiomes Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Microbiomes Market Size by Country (2020-2025)
10.4 Middle East & Africa Microbiomes Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 4D Pharma
11.1.1 4D Pharma Company Details
11.1.2 4D Pharma Business Overview
11.1.3 4D Pharma Microbiomes Introduction
11.1.4 4D Pharma Revenue in Microbiomes Business (2020-2025)
11.1.5 4D Pharma Recent Development
11.2 Enterome BioScience
11.2.1 Enterome BioScience Company Details
11.2.2 Enterome BioScience Business Overview
11.2.3 Enterome BioScience Microbiomes Introduction
11.2.4 Enterome BioScience Revenue in Microbiomes Business (2020-2025)
11.2.5 Enterome BioScience Recent Development
11.3 Evelo Biosciences
11.3.1 Evelo Biosciences Company Details
11.3.2 Evelo Biosciences Business Overview
11.3.3 Evelo Biosciences Microbiomes Introduction
11.3.4 Evelo Biosciences Revenue in Microbiomes Business (2020-2025)
11.3.5 Evelo Biosciences Recent Development
11.4 Ferring
11.4.1 Ferring Company Details
11.4.2 Ferring Business Overview
11.4.3 Ferring Microbiomes Introduction
11.4.4 Ferring Revenue in Microbiomes Business (2020-2025)
11.4.5 Ferring Recent Development
11.5 Osel
11.5.1 Osel Company Details
11.5.2 Osel Business Overview
11.5.3 Osel Microbiomes Introduction
11.5.4 Osel Revenue in Microbiomes Business (2020-2025)
11.5.5 Osel Recent Development
11.6 Second Genome
11.6.1 Second Genome Company Details
11.6.2 Second Genome Business Overview
11.6.3 Second Genome Microbiomes Introduction
11.6.4 Second Genome Revenue in Microbiomes Business (2020-2025)
11.6.5 Second Genome Recent Development
11.7 Seres Therapeutics
11.7.1 Seres Therapeutics Company Details
11.7.2 Seres Therapeutics Business Overview
11.7.3 Seres Therapeutics Microbiomes Introduction
11.7.4 Seres Therapeutics Revenue in Microbiomes Business (2020-2025)
11.7.5 Seres Therapeutics Recent Development
11.8 Synlogic
11.8.1 Synlogic Company Details
11.8.2 Synlogic Business Overview
11.8.3 Synlogic Microbiomes Introduction
11.8.4 Synlogic Revenue in Microbiomes Business (2020-2025)
11.8.5 Synlogic Recent Development
11.9 Synthetic Biologics and Vedanta Biosciences
11.9.1 Synthetic Biologics and Vedanta Biosciences Company Details
11.9.2 Synthetic Biologics and Vedanta Biosciences Business Overview
11.9.3 Synthetic Biologics and Vedanta Biosciences Microbiomes Introduction
11.9.4 Synthetic Biologics and Vedanta Biosciences Revenue in Microbiomes Business (2020-2025)
11.9.5 Synthetic Biologics and Vedanta Biosciences Recent Development
11.10 Vedanta
11.10.1 Vedanta Company Details
11.10.2 Vedanta Business Overview
11.10.3 Vedanta Microbiomes Introduction
11.10.4 Vedanta Revenue in Microbiomes Business (2020-2025)
11.10.5 Vedanta Recent Development
11.11 Rebiotix
11.11.1 Rebiotix Company Details
11.11.2 Rebiotix Business Overview
11.11.3 Rebiotix Microbiomes Introduction
11.11.4 Rebiotix Revenue in Microbiomes Business (2020-2025)
11.11.5 Rebiotix Recent Development
11.12 ActoGeniX
11.12.1 ActoGeniX Company Details
11.12.2 ActoGeniX Business Overview
11.12.3 ActoGeniX Microbiomes Introduction
11.12.4 ActoGeniX Revenue in Microbiomes Business (2020-2025)
11.12.5 ActoGeniX Recent Development
11.13 Enterologics
11.13.1 Enterologics Company Details
11.13.2 Enterologics Business Overview
11.13.3 Enterologics Microbiomes Introduction
11.13.4 Enterologics Revenue in Microbiomes Business (2020-2025)
11.13.5 Enterologics Recent Development
11.14 Metabogen
11.14.1 Metabogen Company Details
11.14.2 Metabogen Business Overview
11.14.3 Metabogen Microbiomes Introduction
11.14.4 Metabogen Revenue in Microbiomes Business (2020-2025)
11.14.5 Metabogen Recent Development
11.15 Metabiomics
11.15.1 Metabiomics Company Details
11.15.2 Metabiomics Business Overview
11.15.3 Metabiomics Microbiomes Introduction
11.15.4 Metabiomics Revenue in Microbiomes Business (2020-2025)
11.15.5 Metabiomics Recent Development
11.16 Ritter Pharmaceuticals
11.16.1 Ritter Pharmaceuticals Company Details
11.16.2 Ritter Pharmaceuticals Business Overview
11.16.3 Ritter Pharmaceuticals Microbiomes Introduction
11.16.4 Ritter Pharmaceuticals Revenue in Microbiomes Business (2020-2025)
11.16.5 Ritter Pharmaceuticals Recent Development
11.17 AvidBiotics
11.17.1 AvidBiotics Company Details
11.17.2 AvidBiotics Business Overview
11.17.3 AvidBiotics Microbiomes Introduction
11.17.4 AvidBiotics Revenue in Microbiomes Business (2020-2025)
11.17.5 AvidBiotics Recent Development
11.18 Symberix
11.18.1 Symberix Company Details
11.18.2 Symberix Business Overview
11.18.3 Symberix Microbiomes Introduction
11.18.4 Symberix Revenue in Microbiomes Business (2020-2025)
11.18.5 Symberix Recent Development
11.19 Miomics
11.19.1 Miomics Company Details
11.19.2 Miomics Business Overview
11.19.3 Miomics Microbiomes Introduction
11.19.4 Miomics Revenue in Microbiomes Business (2020-2025)
11.19.5 Miomics Recent Development
11.20 Symbiotix Biotherapies
11.20.1 Symbiotix Biotherapies Company Details
11.20.2 Symbiotix Biotherapies Business Overview
11.20.3 Symbiotix Biotherapies Microbiomes Introduction
11.20.4 Symbiotix Biotherapies Revenue in Microbiomes Business (2020-2025)
11.20.5 Symbiotix Biotherapies Recent Development
11.21 MicroBiome Therapeutics LLC
11.21.1 MicroBiome Therapeutics LLC Company Details
11.21.2 MicroBiome Therapeutics LLC Business Overview
11.21.3 MicroBiome Therapeutics LLC Microbiomes Introduction
11.21.4 MicroBiome Therapeutics LLC Revenue in Microbiomes Business (2020-2025)
11.21.5 MicroBiome Therapeutics LLC Recent Development
11.22 SciBac Inc
11.22.1 SciBac Inc Company Details
11.22.2 SciBac Inc Business Overview
11.22.3 SciBac Inc Microbiomes Introduction
11.22.4 SciBac Inc Revenue in Microbiomes Business (2020-2025)
11.22.5 SciBac Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
4D Pharma
Enterome BioScience
Evelo Biosciences
Ferring
Osel
Second Genome
Seres Therapeutics
Synlogic
Synthetic Biologics and Vedanta Biosciences
Vedanta
Rebiotix
ActoGeniX
Enterologics
Metabogen
Metabiomics
Ritter Pharmaceuticals
AvidBiotics
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics LLC
SciBac Inc
List of Tables
 Table 1. Global Microbiomes Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Gastrointestinal Microbiome
 Table 3. Key Players of Genitourinary Microbiome
 Table 4. Key Players of Skin Microbiome
 Table 5. Key Players of Respiratory Microbiome
 Table 6. Key Players of Other
 Table 7. Global Microbiomes Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Microbiomes Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Microbiomes Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Microbiomes Market Share by Region (2020-2025)
 Table 11. Global Microbiomes Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Microbiomes Market Share by Region (2026-2031)
 Table 13. Microbiomes Market Trends
 Table 14. Microbiomes Market Drivers
 Table 15. Microbiomes Market Challenges
 Table 16. Microbiomes Market Restraints
 Table 17. Global Microbiomes Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Microbiomes Market Share by Players (2020-2025)
 Table 19. Global Top Microbiomes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiomes as of 2024)
 Table 20. Ranking of Global Top Microbiomes Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Microbiomes Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Microbiomes, Headquarters and Area Served
 Table 23. Global Key Players of Microbiomes, Product and Application
 Table 24. Global Key Players of Microbiomes, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Microbiomes Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Microbiomes Revenue Market Share by Type (2020-2025)
 Table 28. Global Microbiomes Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Microbiomes Revenue Market Share by Type (2026-2031)
 Table 30. Global Microbiomes Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Microbiomes Revenue Market Share by Application (2020-2025)
 Table 32. Global Microbiomes Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Microbiomes Revenue Market Share by Application (2026-2031)
 Table 34. North America Microbiomes Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Microbiomes Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Microbiomes Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Microbiomes Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Microbiomes Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Microbiomes Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Microbiomes Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Microbiomes Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Microbiomes Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Microbiomes Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Microbiomes Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Microbiomes Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Microbiomes Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Microbiomes Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Microbiomes Market Size by Country (2026-2031) & (US$ Million)
 Table 49. 4D Pharma Company Details
 Table 50. 4D Pharma Business Overview
 Table 51. 4D Pharma Microbiomes Product
 Table 52. 4D Pharma Revenue in Microbiomes Business (2020-2025) & (US$ Million)
 Table 53. 4D Pharma Recent Development
 Table 54. Enterome BioScience Company Details
 Table 55. Enterome BioScience Business Overview
 Table 56. Enterome BioScience Microbiomes Product
 Table 57. Enterome BioScience Revenue in Microbiomes Business (2020-2025) & (US$ Million)
 Table 58. Enterome BioScience Recent Development
 Table 59. Evelo Biosciences Company Details
 Table 60. Evelo Biosciences Business Overview
 Table 61. Evelo Biosciences Microbiomes Product
 Table 62. Evelo Biosciences Revenue in Microbiomes Business (2020-2025) & (US$ Million)
 Table 63. Evelo Biosciences Recent Development
 Table 64. Ferring Company Details
 Table 65. Ferring Business Overview
 Table 66. Ferring Microbiomes Product
 Table 67. Ferring Revenue in Microbiomes Business (2020-2025) & (US$ Million)
 Table 68. Ferring Recent Development
 Table 69. Osel Company Details
 Table 70. Osel Business Overview
 Table 71. Osel Microbiomes Product
 Table 72. Osel Revenue in Microbiomes Business (2020-2025) & (US$ Million)
 Table 73. Osel Recent Development
 Table 74. Second Genome Company Details
 Table 75. Second Genome Business Overview
 Table 76. Second Genome Microbiomes Product
 Table 77. Second Genome Revenue in Microbiomes Business (2020-2025) & (US$ Million)
 Table 78. Second Genome Recent Development
 Table 79. Seres Therapeutics Company Details
 Table 80. Seres Therapeutics Business Overview
 Table 81. Seres Therapeutics Microbiomes Product
 Table 82. Seres Therapeutics Revenue in Microbiomes Business (2020-2025) & (US$ Million)
 Table 83. Seres Therapeutics Recent Development
 Table 84. Synlogic Company Details
 Table 85. Synlogic Business Overview
 Table 86. Synlogic Microbiomes Product
 Table 87. Synlogic Revenue in Microbiomes Business (2020-2025) & (US$ Million)
 Table 88. Synlogic Recent Development
 Table 89. Synthetic Biologics and Vedanta Biosciences Company Details
 Table 90. Synthetic Biologics and Vedanta Biosciences Business Overview
 Table 91. Synthetic Biologics and Vedanta Biosciences Microbiomes Product
 Table 92. Synthetic Biologics and Vedanta Biosciences Revenue in Microbiomes Business (2020-2025) & (US$ Million)
 Table 93. Synthetic Biologics and Vedanta Biosciences Recent Development
 Table 94. Vedanta Company Details
 Table 95. Vedanta Business Overview
 Table 96. Vedanta Microbiomes Product
 Table 97. Vedanta Revenue in Microbiomes Business (2020-2025) & (US$ Million)
 Table 98. Vedanta Recent Development
 Table 99. Rebiotix Company Details
 Table 100. Rebiotix Business Overview
 Table 101. Rebiotix Microbiomes Product
 Table 102. Rebiotix Revenue in Microbiomes Business (2020-2025) & (US$ Million)
 Table 103. Rebiotix Recent Development
 Table 104. ActoGeniX Company Details
 Table 105. ActoGeniX Business Overview
 Table 106. ActoGeniX Microbiomes Product
 Table 107. ActoGeniX Revenue in Microbiomes Business (2020-2025) & (US$ Million)
 Table 108. ActoGeniX Recent Development
 Table 109. Enterologics Company Details
 Table 110. Enterologics Business Overview
 Table 111. Enterologics Microbiomes Product
 Table 112. Enterologics Revenue in Microbiomes Business (2020-2025) & (US$ Million)
 Table 113. Enterologics Recent Development
 Table 114. Metabogen Company Details
 Table 115. Metabogen Business Overview
 Table 116. Metabogen Microbiomes Product
 Table 117. Metabogen Revenue in Microbiomes Business (2020-2025) & (US$ Million)
 Table 118. Metabogen Recent Development
 Table 119. Metabiomics Company Details
 Table 120. Metabiomics Business Overview
 Table 121. Metabiomics Microbiomes Product
 Table 122. Metabiomics Revenue in Microbiomes Business (2020-2025) & (US$ Million)
 Table 123. Metabiomics Recent Development
 Table 124. Ritter Pharmaceuticals Company Details
 Table 125. Ritter Pharmaceuticals Business Overview
 Table 126. Ritter Pharmaceuticals Microbiomes Product
 Table 127. Ritter Pharmaceuticals Revenue in Microbiomes Business (2020-2025) & (US$ Million)
 Table 128. Ritter Pharmaceuticals Recent Development
 Table 129. AvidBiotics Company Details
 Table 130. AvidBiotics Business Overview
 Table 131. AvidBiotics Microbiomes Product
 Table 132. AvidBiotics Revenue in Microbiomes Business (2020-2025) & (US$ Million)
 Table 133. AvidBiotics Recent Development
 Table 134. Symberix Company Details
 Table 135. Symberix Business Overview
 Table 136. Symberix Microbiomes Product
 Table 137. Symberix Revenue in Microbiomes Business (2020-2025) & (US$ Million)
 Table 138. Symberix Recent Development
 Table 139. Miomics Company Details
 Table 140. Miomics Business Overview
 Table 141. Miomics Microbiomes Product
 Table 142. Miomics Revenue in Microbiomes Business (2020-2025) & (US$ Million)
 Table 143. Miomics Recent Development
 Table 144. Symbiotix Biotherapies Company Details
 Table 145. Symbiotix Biotherapies Business Overview
 Table 146. Symbiotix Biotherapies Microbiomes Product
 Table 147. Symbiotix Biotherapies Revenue in Microbiomes Business (2020-2025) & (US$ Million)
 Table 148. Symbiotix Biotherapies Recent Development
 Table 149. MicroBiome Therapeutics LLC Company Details
 Table 150. MicroBiome Therapeutics LLC Business Overview
 Table 151. MicroBiome Therapeutics LLC Microbiomes Product
 Table 152. MicroBiome Therapeutics LLC Revenue in Microbiomes Business (2020-2025) & (US$ Million)
 Table 153. MicroBiome Therapeutics LLC Recent Development
 Table 154. SciBac Inc Company Details
 Table 155. SciBac Inc Business Overview
 Table 156. SciBac Inc Microbiomes Product
 Table 157. SciBac Inc Revenue in Microbiomes Business (2020-2025) & (US$ Million)
 Table 158. SciBac Inc Recent Development
 Table 159. Research Programs/Design for This Report
 Table 160. Key Data Information from Secondary Sources
 Table 161. Key Data Information from Primary Sources
 Table 162. Authors List of This Report


List of Figures
 Figure 1. Microbiomes Picture
 Figure 2. Global Microbiomes Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Microbiomes Market Share by Type: 2024 VS 2031
 Figure 4. Gastrointestinal Microbiome Features
 Figure 5. Genitourinary Microbiome Features
 Figure 6. Skin Microbiome Features
 Figure 7. Respiratory Microbiome Features
 Figure 8. Other Features
 Figure 9. Global Microbiomes Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Microbiomes Market Share by Application: 2024 VS 2031
 Figure 11. Testing Case Studies
 Figure 12. Treatment Case Studies
 Figure 13. Diagnosis Case Studies
 Figure 14. Technology Platform Case Studies
 Figure 15. Probiotics Case Studies
 Figure 16. Other Case Studies
 Figure 17. Microbiomes Report Years Considered
 Figure 18. Global Microbiomes Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 19. Global Microbiomes Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 20. Global Microbiomes Market Share by Region: 2024 VS 2031
 Figure 21. Global Microbiomes Market Share by Players in 2024
 Figure 22. Global Top Microbiomes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiomes as of 2024)
 Figure 23. The Top 10 and 5 Players Market Share by Microbiomes Revenue in 2024
 Figure 24. North America Microbiomes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. North America Microbiomes Market Share by Country (2020-2031)
 Figure 26. United States Microbiomes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Canada Microbiomes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Microbiomes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe Microbiomes Market Share by Country (2020-2031)
 Figure 30. Germany Microbiomes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. France Microbiomes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. U.K. Microbiomes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Italy Microbiomes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Russia Microbiomes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Nordic Countries Microbiomes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Microbiomes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Microbiomes Market Share by Region (2020-2031)
 Figure 38. China Microbiomes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Japan Microbiomes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. South Korea Microbiomes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Microbiomes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. India Microbiomes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Australia Microbiomes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Microbiomes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America Microbiomes Market Share by Country (2020-2031)
 Figure 46. Mexico Microbiomes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Brazil Microbiomes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Microbiomes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa Microbiomes Market Share by Country (2020-2031)
 Figure 50. Turkey Microbiomes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Microbiomes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. UAE Microbiomes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. 4D Pharma Revenue Growth Rate in Microbiomes Business (2020-2025)
 Figure 54. Enterome BioScience Revenue Growth Rate in Microbiomes Business (2020-2025)
 Figure 55. Evelo Biosciences Revenue Growth Rate in Microbiomes Business (2020-2025)
 Figure 56. Ferring Revenue Growth Rate in Microbiomes Business (2020-2025)
 Figure 57. Osel Revenue Growth Rate in Microbiomes Business (2020-2025)
 Figure 58. Second Genome Revenue Growth Rate in Microbiomes Business (2020-2025)
 Figure 59. Seres Therapeutics Revenue Growth Rate in Microbiomes Business (2020-2025)
 Figure 60. Synlogic Revenue Growth Rate in Microbiomes Business (2020-2025)
 Figure 61. Synthetic Biologics and Vedanta Biosciences Revenue Growth Rate in Microbiomes Business (2020-2025)
 Figure 62. Vedanta Revenue Growth Rate in Microbiomes Business (2020-2025)
 Figure 63. Rebiotix Revenue Growth Rate in Microbiomes Business (2020-2025)
 Figure 64. ActoGeniX Revenue Growth Rate in Microbiomes Business (2020-2025)
 Figure 65. Enterologics Revenue Growth Rate in Microbiomes Business (2020-2025)
 Figure 66. Metabogen Revenue Growth Rate in Microbiomes Business (2020-2025)
 Figure 67. Metabiomics Revenue Growth Rate in Microbiomes Business (2020-2025)
 Figure 68. Ritter Pharmaceuticals Revenue Growth Rate in Microbiomes Business (2020-2025)
 Figure 69. AvidBiotics Revenue Growth Rate in Microbiomes Business (2020-2025)
 Figure 70. Symberix Revenue Growth Rate in Microbiomes Business (2020-2025)
 Figure 71. Miomics Revenue Growth Rate in Microbiomes Business (2020-2025)
 Figure 72. Symbiotix Biotherapies Revenue Growth Rate in Microbiomes Business (2020-2025)
 Figure 73. MicroBiome Therapeutics LLC Revenue Growth Rate in Microbiomes Business (2020-2025)
 Figure 74. SciBac Inc Revenue Growth Rate in Microbiomes Business (2020-2025)
 Figure 75. Bottom-up and Top-down Approaches for This Report
 Figure 76. Data Triangulation
 Figure 77. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Microbiome Therapies Market Research Report 2024
Global Gut Microbiota Market Research Report 2024
Global Cancer Microbiome Market Research Report 2024
Global Human Microbiome Sequencing Market Research Report 2024
Global Microbial Food Cultures Market Research Report 2025
Home Gut Microbiome Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Agricultural Microbiome Analysis Service Market Research Report 2025
Global Microbiome Cosmetic Product Market Research Report 2025
Cancer Microbiome Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Microbial Sampler Market Research Report 2024
Global Human Microbiome Sequencing Technology Market Research Report 2024
Pet Gut Microbiome Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Microbiome Therapeutic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Microbial Fermenters Market Research Report 2025
Global Fecal Microbiota Bank Market Research Report 2025
Global Gut Microbiome Market Research Report 2024
Global Agricultural Microbials Market Research Report 2024
Global Microbiological Culture Medium Market Research Report 2024
Microbiome Therapeutics and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Microbial Fermentation Technology for Food Market Research Report 2024

RELATED REPORTS

Global Geriatric Care Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17Q6174
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Hospice Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Z4276
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Geriatric Care Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Q8325
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Allied Health Care Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29V19536
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions